Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential Approaches Versus Approved or Developing Chronic Myeloid Leukemia Therapy
Emanuela Andretta, Caterina Costa, Consiglia Longobardi, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 24

Showing 24 citing articles:

Chronic Myeloid Leukemia, from Pathophysiology to Treatment-Free Remission: A Narrative Literature Review
Ikhwan Rinaldi, Kevin Winston
Journal of Blood Medicine (2023) Vol. Volume 14, pp. 261-277
Open Access | Times Cited: 31
A Comprehensive Review of Cancer Drug–Induced Cardiotoxicity in Blood Cancer Patients: Current Perspectives and Therapeutic Strategies
Vincenzo Costanzo, Yashwant Kumar Ratre, Emanuela Andretta, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 4, pp. 465-495
Closed Access | Times Cited: 9
Generation of Reactive Oxygen Species (ROS) by Harmful Algal Bloom (HAB)-Forming Phytoplankton and Their Potential Impact on Surrounding Living Organisms
Kichul Cho, M. Ueno, Yan Liang, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 206-206
Open Access | Times Cited: 22
CircRNA: a rising star in leukemia
Qianan Li, Xinxin Ren, Ying Wang, et al.
PeerJ (2023) Vol. 11, pp. e15577-e15577
Open Access | Times Cited: 13
A practical guide to managing cardiopulmonary toxicities of tyrosine kinase inhibitors in chronic myeloid leukemia
Rasha Kaddoura, Wafer Dabdoob, Khalid Ahmed, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 11
Structure and Dynamics of the ABL1 Tyrosine Kinase and Its Important Role in Chronic Myeloid Leukemia
Ayca Irgit, Reyhan Kamıs, Belgin Sever, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 5
Open Access
Capsaicin Exerts Antitumor Activity in Mesothelioma Cells
Emanuela Andretta, Aurora Costa, Elisa Ventura, et al.
Nutrients (2024) Vol. 16, Iss. 21, pp. 3758-3758
Open Access | Times Cited: 3
BCR/ABL-Positive Chronic Myeloid Leukemia in Children: Current Treatment Approach
Jenna M. Menger, Ryan S. Sathianathen, Kathleen M. Sakamoto, et al.
Current Oncology Reports (2024) Vol. 26, Iss. 3, pp. 250-257
Closed Access | Times Cited: 2
Neuroimmune crosstalk and its impact on cancer therapy and research
Iman Sharawy
Discover Oncology (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 7
The Microalga Skeletonema marinoi Induces Apoptosis and DNA Damage in K562 Cell Line by Modulating NADPH Oxidase
Roberto Ciarcia, Consiglia Longobardi, Gianmarco Ferrara, et al.
Molecules (2022) Vol. 27, Iss. 23, pp. 8270-8270
Open Access | Times Cited: 5
Novel Antibody Exerts Antitumor Effect through Downregulation of CD147 and Activation of Multiple Stress Signals
Keisuke Fukuchi, Kayoko Nanai, Hiroshi Yuita, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 5
Increased copy number of imprinted genes in the chromosomal region 20q11-q13.32 is associated with resistance to antitumor agents in cancer cell lines
Julia Krushkal, Suleyman Vural, Travis L. Jensen, et al.
Clinical Epigenetics (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Role of miRNAs to control the progression of Chronic Myeloid Leukemia by their expression levels
Manvi Bansal, Sana Ansari, Malkhey Verma
Medical Oncology (2024) Vol. 41, Iss. 2
Closed Access
Clinical applications of abnormal DNA methylation in chronic myeloid leukemia.
Lingyan Zhou, Xiao-Cheng Yin
PubMed (2024) Vol. 49, Iss. 1, pp. 122-127
Closed Access
Women in Science - Hematology 2023

Frontiers research topics (2024)
Open Access
Increasing outer membrane complexity: the case of the lipopolysaccharide lipid A from marine Cellulophaga pacifica
Emanuela Andretta, Stefania De Chiara, Chiara Pagliuca, et al.
Glycoconjugate Journal (2024) Vol. 41, Iss. 2, pp. 119-131
Open Access
Current Status and Management of Chronic Myeloid Leukemia in the Gulf Region: Survey Results and Expert Opinion
Giuseppe Saglio, Mohamed A. Yassin, Ahmad Alhuraiji, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2114-2114
Open Access
Research Progress of B-Cell Lymphoma/Leukemia-2 Inhibitor Combined with Azacytidine in the Targeted Therapy of Acute Myeloid Leukemia
Yanyu Wang, Dan Huang, Lejia Liu, et al.
Computational and Mathematical Methods in Medicine (2022) Vol. 2022, pp. 1-8
Open Access | Times Cited: 2
Advances in the Treatment of Chronic Myeloid Leukemia
Romeo-Gabriel Mihăilă
Recent Patents on Anti-Cancer Drug Discovery (2023) Vol. 19, Iss. 1, pp. 1-17
Closed Access
Peer Review #1 of "CircRNA: a rising star in leukemia (v0.2)"
Qianan Li, Xinxin Ren, Ying Wang, et al.
(2023)
Open Access
Peer Review #2 of "CircRNA: a rising star in leukemia (v0.1)"
Qianan Li, Xinxin Ren, Ying Wang, et al.
(2023)
Open Access
Peer Review #1 of "CircRNA: a rising star in leukemia (v0.1)"
Qianan Li, Xinxin Ren, Ying Wang, et al.
(2023)
Open Access
Peer Review #3 of "CircRNA: a rising star in leukemia (v0.2)"
Qianan Li, Xinxin Ren, Ying Wang, et al.
(2023)
Open Access
Peer Review #3 of "CircRNA: a rising star in leukemia (v0.1)"
Qianan Li, Xinxin Ren, Ying Wang, et al.
(2023)
Open Access
Page 1

Scroll to top